BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 1651674)

  • 1. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
    Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
    Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
    Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
    Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
    Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to hepatitis C virus and liver disease in volunteer blood donors.
    Alberti A; Chemello L; Cavalletto D; Tagger A; Dal Canton A; Bizzaro N; Tagariello G; Ruol A
    Ann Intern Med; 1991 Jun; 114(12):1010-2. PubMed ID: 1851402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of HCV infection by RIBA indeterminate and positive blood units.
    Kolho E; Naukkarinen R; Krusius T
    Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors.
    McCaughan GW; McGuinness PH; Bishop GA; Painter DM; Lien AS; Tulloch R; Wylie BR; Archer GT
    Med J Aust; 1992 Aug; 157(4):231-3. PubMed ID: 1279365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse.
    Bassily S; Hyams KC; Fouad RA; Samaan MD; Hibbs RG
    Am J Trop Med Hyg; 1995 Jun; 52(6):503-5. PubMed ID: 7541968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis C virus (HCV) screening at a Canadian Red Cross center: significance of a positive c100 HCV enzyme-linked immunosorbent assay.
    Giulivi A; Aye MT; Gray E; Scalia V; Gill P; Cheng G
    Transfusion; 1992 May; 32(4):309-11. PubMed ID: 1374940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
    Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
    Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.